Interleukin-based anti-cancer therapy: Interleukin-37 (IL-37) increases the expression of PTEN via down regulation of its target gene, 11/March/2015, 09.43 am

MiRNA-based regenerative therapy for Injured tissues: MiRNA-138 promotes epithelial regeneration and tissue growth via downregulation of its target gene, 11/March/2015, 9.40 am
March 11, 2015
Natural product-based therapy for Inflammation-mediated cancers: Luteolin, a flavone found in celery, green peppers, and chamomile tea, increases the expression of oncogenic suppressor PTX3 and inhibits complement-dependent inflammation via down regulation of its target gene, 11/March/2015, 11.57 am
March 11, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Web: http://genomediscovery.org

Significance:  This study suggests, for the first time, Interleukin-37 (IL-37), by suppressing the expression of its target gene, it may increase the expression of tumor suppressor  PTEN. Thus, pharmacological formulations encompassing “IL-37 or its activators”  can be used to inhibit the progression of human tumors.

CitationBoominathan, Interleukin-based anti-cancer therapy: Interleukin-37 (IL-37) increases the expression of  PTEN via down regulation of its target gene, 11/March/2015,  09.43 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How IL-37 increases the expression of tumor suppressor PTEN

* Research cooperation

Comments are closed.